Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Premium and service revenues $ 70,364 $ 56,435 $ 45,620
Premium tax and health insurer fee 4,275 3,681 2,762
Total revenues 74,639 60,116 48,382
Expenses:      
Medical costs 58,862 46,057 37,851
Cost of services 2,465 2,386 1,847
Selling, general and administrative expenses 6,533 6,043 4,446
Amortization of acquired intangible assets 258 211 156
Premium tax expense 4,469 3,252 2,883
Health insurer fee expense 0 709 0
Impairment loss 271 0 0
Total operating expenses 72,858 58,658 47,183
Earnings from operations 1,781 1,458 1,199
Other income (expense):      
Investment and other income 443 253 190
Debt extinguishment costs (30) 0 0
Interest expense (412) (343) (255)
Earnings from operations, before income tax expense 1,782 1,368 1,134
Income tax expense 473 474 326
Net earnings 1,309 894 808
Loss attributable to noncontrolling interests 12 6 20
Net earnings attributable to Centene Corporation $ 1,321 $ 900 $ 828
Net earnings per common share attributable to Centene Corporation:      
Basic earnings per common share (in usd per share) $ 3.19 $ 2.31 $ 2.40
Diluted earnings per common share (in usd per share) $ 3.14 $ 2.26 $ 2.34
Weighted average number of common shares outstanding:      
Basic (in shares) 413,487 390,248 344,853
Diluted (in shares) 420,409 398,506 353,404
Premium      
Revenues:      
Premium and service revenues $ 67,439 $ 53,629 $ 43,353
Service      
Revenues:      
Premium and service revenues $ 2,925 $ 2,806 $ 2,267